Illumacell Website

Waterloo, CA · 1 known investors

Illumacell is a clinical-stage biotech company developing a non-invasive photodynamic therapy for cancer, combining its patented "Wall-of-Light" medical light device with the off-patent drug 5-ALA to destroy tumor cells at depth without surgery. It is pursuing Oral Potentially Malignant Disorders as a lead indication and is conducting early-stage clinical studies in Canada.

BiotechHealthtechMedical Devices